# Efficacy and Safety of Bulevirtide (BLV) Therapy in HDV Chronic Hepatitis (CHD) in Italy

> **NCT05962307** · — · COMPLETED · sponsor: **Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico** · enrollment: 50 (actual)

## Conditions studied

- Hepatitis D

## Interventions

- **DRUG:** Bulevirtide

## Key facts

- **NCT ID:** NCT05962307
- **Lead sponsor:** Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-04-01
- **Primary completion:** 2023-04-30
- **Final completion:** 2023-05-31
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2023-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05962307

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05962307, "Efficacy and Safety of Bulevirtide (BLV) Therapy in HDV Chronic Hepatitis (CHD) in Italy". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05962307. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*